BioXcel Therapeutics, Inc.
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
BTAI | NDAQ
Overview
Corporate Details
- ISIN(s):
- US09075P2048
- LEI:
- Country:
- United States of America
- Address:
- 555 LONG WHARF DRIVE, 6511 NEW HAVEN
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company that utilizes artificial intelligence (AI) to develop transformative medicines. The company's primary focus is on neuroscience and immuno-oncology. It employs a proprietary AI-based drug re-innovation platform to identify new therapeutic applications for existing drugs and novel compounds, aiming to address significant unmet medical needs by developing innovative treatments for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioXcel Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioXcel Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioXcel Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
